| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-08 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.22 | 8e-07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-06 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-06 |